Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Sheagren

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Archives of Internal Medicine|December 1, 1986
Staphylococcus aureus bacteremia. Potential impact of a new blood culture techniqueJ N Sheagren
The New England Journal of Medicine|May 24, 1984
Staphylococcus aureus. The persistent pathogen (first of two parts)J N Sheagren
The American Journal of Medicine|May 15, 1984
Treatment of skin and skin structure infections in the patient at riskJ N Sheagren
Archives of Internal Medicine|October 1, 1992
Nasal carriage of Staphylococcus aureus and intravenous catheter phlebitis and sepsisJ N Sheagren
Critical Care Medicine|May 13, 1999
Staphylococcus aureus infections in trauma patientsJ N Sheagren
Archives of Internal Medicine|February 1, 1984
Guidelines for the use of the teichoic acid antibody assayJ N Sheagren
The New England Journal of Medicine|May 31, 1984
Staphylococcus aureus. The persistent pathogen (second of two parts)J N Sheagren
Infectious Disease Clinics of North America|December 1, 1991
Corticosteroids for the treatment of septic shockJ N Sheagren
Cutis|November 15, 1985
Staphylococcal infections of the skin and skin structuresJ N Sheagren
The Western Journal of Medicine|February 1, 1986
Treatment of bacteremiaJ N Sheagren
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Archives of Internal Medicine|December 1, 1986
Staphylococcus aureus bacteremia. Potential impact of a new blood culture techniqueJ N Sheagren
The New England Journal of Medicine|May 24, 1984
Staphylococcus aureus. The persistent pathogen (first of two parts)J N Sheagren
The American Journal of Medicine|May 15, 1984
Treatment of skin and skin structure infections in the patient at riskJ N Sheagren
Archives of Internal Medicine|October 1, 1992
Nasal carriage of Staphylococcus aureus and intravenous catheter phlebitis and sepsisJ N Sheagren
Critical Care Medicine|May 13, 1999
Staphylococcus aureus infections in trauma patientsJ N Sheagren
Archives of Internal Medicine|February 1, 1984
Guidelines for the use of the teichoic acid antibody assayJ N Sheagren
The New England Journal of Medicine|May 31, 1984
Staphylococcus aureus. The persistent pathogen (second of two parts)J N Sheagren
Infectious Disease Clinics of North America|December 1, 1991
Corticosteroids for the treatment of septic shockJ N Sheagren
Cutis|November 15, 1985
Staphylococcal infections of the skin and skin structuresJ N Sheagren
The Western Journal of Medicine|February 1, 1986
Treatment of bacteremiaJ N Sheagren
Pageof 8